Transchem Ltd Stock Analysis

BSE: 500422 | NSE: TRANSCHEM | Agriculture | Small Cap

BSE Share Price 02-Dec-2022 18:01
26.35 0.40 (1.54%)

DeciZen - Make an Informed Decision on Transchem

M-Cap below 100cr DeciZen not available

Transchem Price Chart

P/E Ratio (SA) :
13.80
Market Cap :
32.3 Cr.
52-wk low :
16.3
52-wk high :
38
Bole Toh?

1. Is Transchem Ltd a good quality company?

Data is not available for this company.

2. Is Transchem Ltd undervalued or overvalued?

The key valuation ratios of Transchem Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Transchem Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transchem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Transchem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % -1.3%-1.6%0.3%-2.9%-3.4%-4.9%0.4%1.1%48.5%4.4%-
Value Creation Index -1.1-1.1-1.0-1.2-1.2-1.4-1.0-0.92.5-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0000000022.500
YoY Gr. Rt. %-NANANANANANANANA-100%-
Adj EPS -0.6-0.60.1-0.9-1.1-1.50.10.319.72.31.9
YoY Gr. Rt. %-NANA-1010%NANANA135.7%5878.8%-88.1%-
BVPS (₹) 31.931.231.331.43130.1313051.454.253.8
Adj Net Profit -0.7-0.70.1-1.1-1.3-1.80.20.424.22.92
Cash Flow from Ops. 1.80.60.91.10.6-19.810.3-0.6-27.721.9-
Debt/CF from Ops. 0.9000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA-100%
Adj EPS NANA155.7%-88.1%
BVPS 6.111.820.45.4
Share Price 1.5% 1.1% 26.5% 41.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % -1.8-1.80.3-2.9-3.4-4.90.41.148.54.43.5
Op. Profit Mgn % 0000000091.400
Net Profit Mgn % 00000000107.500
Debt to Equity 00000000000
Working Cap Days 0000000045700
Cash Conv. Cycle 00000000100

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 155.68%

Return on Equity has declined versus last 3 years average to 3.50%

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Transchem Ltd.

Standalone Consolidated
TTM EPS (₹) 1.9 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 53.8 -
Reserves (₹ Cr.) 54 -
P/BV 0.49 -
PE 13.80 -
From the Market
52 Week Low / High (₹) 16.30 / 38.00
All Time Low / High (₹) 2.55 / 95.00
Market Cap (₹ Cr.) 32.3
Equity (₹ Cr.) 12.2
Face Value (₹) 10
Industry PE 18.4

Management X-Ray of Transchem :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Transchem

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Transchem Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Transchem on 02-Dec-2022 18:01 is : 26.35.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 02-Dec-2022 18:01 the market cap of Transchem stood at ₹ 32.25.
The latest PE ratio of Transchem as of 02-Dec-2022 18:01 is 13.80.
The latest PB ratio of Transchem as of 02-Dec-2022 18:01 is 0.49
The 52-week high of Transchem is ₹ 38.00 and the 52-week low is ₹ 16.30.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Transchem is ₹ 0.00 ( Cr.) .

About Transchem Ltd

Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.

The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use API’s.

The company is having four state of the art GMP approved facilities at multiple locations in India, with total production capacity of 500 MT per annum.

The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.

Products and services offered by the company:

Services:

  • Contract Research Facility.
  • Custom Synthesis of Molecules.
  • Contract Manufacturing of API's as per GMP Guidelines.
  • Intermediates.
  • Veterinary Formulations.
  • Q.A. & Regulatory Support.

Product:

Anthelmintics

  • Albendazole USP / EP /BP
  • Ricobendazole (Albendazole Sulphoxide)
  • Mebendazole EP / BP / USP / POLY 'C'
  • Oxyclozanide BP VET
  • Closantel Sodium EP / BASE
  • Clorsulon USP
  • Nitroscanate
  • Fenbendazole EP/BP/BP VET
  • Oxfendazole BP VET / EP
  • Flubendazole EP / 98%
  • Nitroxynil BP VET
  • Rafoxanide BP VET
  • Triclabendazole
  • Praziquantel BP / USP

Veterinary API's

  • Diminazene Diaceturate B VET C
  • Quinapyramine Salts B VET C
  • Parvaquone
  • Toldimfos Sodium
  • Acepromazine Maleate BP VET
  • Butaphosphan
  • Flunixin Meglumine USP
  • Homidium Bromide / Chloride
  • Isometamedium

Ectoparaciticides

  • Cyromazine.
  • Cymiazole
  • S-Methoprene
  • Azamethiphos.

Human Use API's

  • Ramipril EP
  • Frusemide EP / BP / USP
  • Gabapentin USP
  • Cetirizine DI HCL EP/BP
  • Lamotrigine
  • Pentamidine Isetionate BP
  • Succinylcholine Chloride USP
  • Epinastine HCL
  • Nifuroxazide
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now